Product Code: 16211 (90 softgels)
EN 122417
fücoTHIN is non-Stimulant Thermogenic
#1 Selling Diet Formula in the US Natural Products Industry (SPINS Scana data ending 06/11/11)
fücoTHIN is a proprietary blend of fucoxanthin, derived from seaweed and a virgin, cold-pressed pomegranate oil. The blend, called Xanthigen™ utilizes uniquely effective means for extracting fucoxanthin from seaweed and then blends it with the highest quality pomegranate oil in unique proportions in order to create a patent pending formula.
To be used in conjunction with a healthy diet and exercise plan to support weight loss and body fat reduction. fücoTHIN® is a natural health product that is made with a proprietary concentration of fucoxanthin for a patent pending formula that is naturally thermogenic.
Thermogenesis is the process by which the body increases its metabolic rate, requiring utilization of internal stores of energy such as fat.
• Clinically Researched Formula
• Concentrated Fucoxanthin
• Supports Healthy Body Fat Reduction
• No Caffeine and no Guarana
Dairy free. Contains no artificial colours or preservatives.
Each softgel contains:
Undaria pinnatifida/Laminaria japonica (brown seaweed) whole plant extract standardized to 0.82mg fucoxanthin 100mg
Punica granatum (pomegranate) seed oil standardized to at least 70% punicic acid 100mg
The Evidence:
A total of 150 women participated in two clinical studies: 40 in the Metabolic Rate Study and 110 in the Weight Loss Study. The average age of the women in the group was 38 and all participants were clinically obese. Both studies lasted 16 weeks, and in both all the participants were counseled to follow an 1800 calorie diet.
The Metabolic Rate Study concluded that there was a statistically significant difference between the group taking Xanthigen and the placebo control group. They found the group taking Xanthigen (fücoTHIN) had a metabolic rate increase that averaged 18.2% higher than the placebo group.
The Weight Loss Study made similar statistically significant findings: There were two groups who took Xanthigen (fücoTHIN) in this study: those with non-alcoholic fatty liver disease (NAFLD) and those with normal liver fat (NLF). The group with NAFLD lost an average of 15.2 pounds while the group with NLF lost an average of 13.9 pounds. The average of both groups which is the entire study group taking Xanthigen lost an average of 14 ½lbs. The placebo group only lost 3 lbs. Mathematically, those who took fücoTHIN lost over 4 ½ times more weight than those who just dieted.
